JP2010526085A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526085A5 JP2010526085A5 JP2010506590A JP2010506590A JP2010526085A5 JP 2010526085 A5 JP2010526085 A5 JP 2010526085A5 JP 2010506590 A JP2010506590 A JP 2010506590A JP 2010506590 A JP2010506590 A JP 2010506590A JP 2010526085 A5 JP2010526085 A5 JP 2010526085A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- infection
- halogenated amino
- amino acid
- chlorotaurine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000009472 formulation Methods 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 32
- 150000001413 amino acids Chemical class 0.000 claims description 13
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 13
- 206010057190 Respiratory tract infections Diseases 0.000 claims description 9
- 208000015181 infectious disease Diseases 0.000 claims description 9
- NMMHHSLZJLPMEG-UHFFFAOYSA-N 2-(chloroamino)ethanesulfonic acid Chemical compound OS(=O)(=O)CCNCl NMMHHSLZJLPMEG-UHFFFAOYSA-N 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 239000000043 antiallergic agent Substances 0.000 claims description 4
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 206010058803 Oesophageal infection Diseases 0.000 claims description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical class 0.000 claims description 2
- 230000000845 anti-microbial effect Effects 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 230000002685 pulmonary effect Effects 0.000 claims description 2
- 208000020029 respiratory tract infectious disease Diseases 0.000 claims description 2
- 230000002500 effect on skin Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 10
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91527707P | 2007-05-01 | 2007-05-01 | |
| PCT/US2008/061956 WO2008137444A1 (en) | 2007-05-01 | 2008-04-30 | N-halogenated amino acid formulations with anti-inflammatory compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010526085A JP2010526085A (ja) | 2010-07-29 |
| JP2010526085A5 true JP2010526085A5 (enExample) | 2012-06-07 |
Family
ID=39495776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506590A Withdrawn JP2010526085A (ja) | 2007-05-01 | 2008-04-30 | 抗炎症化合物によるｎ−ハロゲン化アミノ酸処方物 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20080275122A1 (enExample) |
| EP (1) | EP2139519A1 (enExample) |
| JP (1) | JP2010526085A (enExample) |
| KR (1) | KR20100017159A (enExample) |
| CN (1) | CN101687041A (enExample) |
| AR (1) | AR066372A1 (enExample) |
| AU (1) | AU2008247788A1 (enExample) |
| BR (1) | BRPI0810962A2 (enExample) |
| CA (1) | CA2684186A1 (enExample) |
| CL (1) | CL2008001282A1 (enExample) |
| MX (1) | MX2009011818A (enExample) |
| RU (1) | RU2009144286A (enExample) |
| TW (1) | TW200901957A (enExample) |
| UY (1) | UY31058A1 (enExample) |
| WO (1) | WO2008137444A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2265267B1 (en) * | 2008-04-10 | 2016-09-21 | Waldemar Gottardi | Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections |
| WO2009127924A1 (en) * | 2008-04-15 | 2009-10-22 | Waldemar Gottardi | Compositions and devices for antisepsis and anticoagulation |
| CN103747770A (zh) | 2011-06-15 | 2014-04-23 | Rls全球股份公司 | 龋牙本质组织的检测和除去 |
| SE536581C2 (sv) | 2012-07-24 | 2014-03-11 | Rls Global Ab | Ett kit för behandling av sår eller liknande och ett preparat och metoder därav |
| US20140227201A1 (en) * | 2013-02-13 | 2014-08-14 | Novabay Pharmaceuticals, Inc. | Antimicrobial Gel Formulations |
| KR102253324B1 (ko) * | 2019-11-27 | 2021-05-18 | 단디바이오사이언스 주식회사 | 호흡기 질환의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1325382C (en) * | 1988-01-27 | 1993-12-21 | Takahiro Ogawa | Locally administrable therapeutic composition for inflammatory disease |
| US5421818A (en) * | 1993-10-18 | 1995-06-06 | Inner Ear Medical Delivery Systems, Inc. | Multi-functional inner ear treatment and diagnostic system |
| US5475034A (en) * | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| US6156728A (en) * | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
| AU2001261748A1 (en) * | 2000-05-19 | 2001-12-03 | Alcon Laboratories Inc. | Antibiotic compositions for treatment of the eye, ear and nose |
| AR031135A1 (es) * | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
| WO2003061566A2 (en) * | 2002-01-24 | 2003-07-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Anti-cancer combination and use thereof |
| PL1656095T3 (pl) * | 2003-08-18 | 2014-04-30 | Novabay Pharmaceuticals Inc | N,n-dwuchlorowcowane kwasy aminowe i pochodne |
| TWI386201B (zh) * | 2005-01-25 | 2013-02-21 | Novabay Pharmaceuticals Inc | Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法 |
| UY31059A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado |
-
2008
- 2008-04-29 UY UY31058A patent/UY31058A1/es not_active Application Discontinuation
- 2008-04-30 AR ARP080101843A patent/AR066372A1/es not_active Application Discontinuation
- 2008-04-30 CA CA002684186A patent/CA2684186A1/en not_active Abandoned
- 2008-04-30 EP EP08780580A patent/EP2139519A1/en not_active Withdrawn
- 2008-04-30 CN CN200880013887A patent/CN101687041A/zh active Pending
- 2008-04-30 MX MX2009011818A patent/MX2009011818A/es unknown
- 2008-04-30 BR BRPI0810962-1A2A patent/BRPI0810962A2/pt not_active IP Right Cessation
- 2008-04-30 TW TW097115859A patent/TW200901957A/zh unknown
- 2008-04-30 KR KR1020097024160A patent/KR20100017159A/ko not_active Withdrawn
- 2008-04-30 JP JP2010506590A patent/JP2010526085A/ja not_active Withdrawn
- 2008-04-30 WO PCT/US2008/061956 patent/WO2008137444A1/en not_active Ceased
- 2008-04-30 RU RU2009144286/15A patent/RU2009144286A/ru not_active Application Discontinuation
- 2008-04-30 AU AU2008247788A patent/AU2008247788A1/en not_active Abandoned
- 2008-04-30 US US12/112,352 patent/US20080275122A1/en not_active Abandoned
- 2008-05-02 CL CL2008001282A patent/CL2008001282A1/es unknown
-
2010
- 2010-04-26 US US12/767,420 patent/US20100210730A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010526085A5 (enExample) | ||
| JP2012522037A5 (enExample) | ||
| JP2009526751A5 (enExample) | ||
| JP2018021051A5 (enExample) | ||
| JP2009533356A5 (enExample) | ||
| JP2017531038A5 (enExample) | ||
| RU2005135016A (ru) | Производные хинолина в качестве ингибиторов фосфодиэстеразы | |
| JP2014516954A5 (enExample) | ||
| JP2004525903A5 (enExample) | ||
| CA2818938A1 (en) | Compounds for treating respiratory syncytial virus infections | |
| CA2777746A1 (en) | Benzoimidazole compounds and uses thereof | |
| JP2013513612A5 (enExample) | ||
| JP2012532115A5 (enExample) | ||
| JP2017513920A5 (enExample) | ||
| RU2012103458A (ru) | Композиции, включающие финафлоксации, и способы лечения офтальмологических, ушных или назальных инфекций | |
| JP2013510169A5 (enExample) | ||
| JP2009544665A5 (enExample) | ||
| RU2009144286A (ru) | Составы с n-галогензамещенной аминокислотой и противовоспалительными соединениями | |
| RU2489433C9 (ru) | Производное циклобутилпурина, агент, активирующий ангиогенез, агент, активирующий образование просвета, агент, активирующий рост нейронов, и лекарственное средство | |
| JP2010526082A5 (enExample) | ||
| RU2009144292A (ru) | Препараты n-галогенированных аминокислот | |
| WO2009102808A3 (en) | Doxorubicin adjuvants to reduce toxicity and methods for using the same | |
| JP2010526084A5 (enExample) | ||
| WO2021038529A1 (en) | Treatment and prophylaxis of viral infections | |
| EP2265267A1 (en) | Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections |